Research indicates that ZNF217 is involved in various human cancers, including breast cancer 14, ovarian cancer 15, stomach cancer 16, colon cancer 17, prostate cancer 18, glioblastoma 19, lung cancer 20, and lymphoma 21, as well as with the precancerous condition Barrett's esophagus 22. This evidence concerns the gene ZNF217 and breast carcinoma.